Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 2 Withdrawn 1 Unknown 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 28 Carcinoma, Non-Small-Cell Lung 20 Triple Negative Breast Neoplasms 9 Ovarian Neoplasms 8 Lung Neoplasms 8 Uterine Cervical Neoplasms 6 Adenocarcinoma of Lung 6 Neoplasms 5 Neoplasm Metastasis 5 Esophageal Neoplasms 5 Carcinoma, Ovarian Epithelial 4 Stomach Neoplasms 3 Recurrence 3 Prostatic Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Platinum-Refractory Fallopian Tube Carcinoma 2 Pancreatic Neoplasms 2 Head and Neck Neoplasms 2 Fallopian Tube Neoplasms 2 Adenocarcinoma, Bronchiolo-Alveolar 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Recurrent High Grade Uterine Cancer 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1

Interventions

Gemcitabine 3 Cisplatin 3 Irinotecan 2 Fluorouracil 2 Capecitabine 2 tremelimumab 1 pamiparib 1 durvalumab 1 brigimadlin 1 atezolizumab 1 Temozolomide 1 Surgical Procedures, Operative 1 Paclitaxel 1 Oxaliplatin 1 Nivolumab 1 Leucovorin 1 IMC-001 1 Blood Specimen Collection 1 ARX788 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Biliary Tract Neoplasms × Paclitaxel × Clear all

NCT03818997 2020-02-05

DYNAMIC

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Withdrawn

Gastrointestinal

Biliary Tract Neoplasms, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡